CAS: 7113-10-2; 2-Phenylthiazole-4-Carboxylic Acid

该化合物是一种有机化合物,其特点是含有硫磺和氮原子的硫化环,有助于其独特的化学特性;该化合物的特征是附于硫化氮的苯基组,增强了其芳香特性并有可能影响其活性和溶性;在硫化氮环的4个位置上,箱酸功能组(-COOH)传播酸性特性,允许氢结合并增加其极度;该化合物由于生物活动和形成协调综合体的能力,经常因其在制药,农用化学品和材料科学方面的潜在应用而加以研究;其结构特征还有助于其光物理特性,使其对有机电子材料的开发具有兴趣;

结构式图片

欧盟法规

C&L通报

上下游产品

CAS号59937-01-8 2-苯基噻唑-4-甲酸乙酯 | CAS号7113-02-2 2-苯基噻唑-4-羧酸甲酯 | CAS号1113-59-3 3-溴丙酮酸 | CAS号2227-79-4 硫代苯甲酰胺 | CAS号23780-13-4 (2-苯基噻唑-4-基)甲醇 | CAS号38707-83-4 2-苯基-1,3-噻唑-4,5-二羧酸 | CAS号4771-31-7 4-(氯甲基)-2-苯基-1,3-噻唑 | CAS号54986-96-8 diethyl 2-pheny... | CAS号99380-81-1 2-苯基噻唑烷-4-羧酸甲酯 | CAS号100-52-7 苯甲醛 | CAS号36094-04-9 2-苯基-1,3-噻唑-4-甲酰氯 | CAS号10045-52-0 1-(2-苯基-1,3-噻唑-... | CAS号7113-02-2 2-苯基噻唑-4-羧酸甲酯 | CAS号400775-03-3 2-phenyl-1,3-th...

合成工艺路线路线简述

    📜硫代苯甲酰胺置于lithium Hydroxide Monohydrate体系中,用 四氢呋喃,甲醇,乙醇,水 作为反应溶剂,化学反应 8.0H,反应生成 2-苯基-1,3-噻唑-4-甲酸
    参考文献:发现了2-苯基噻唑-4-羧酸,一种新型有效的黄嘌呤氧化酶抑制剂.
    标题:发现了2-苯基噻唑-4-羧酸,一种新型有效的黄嘌呤氧化酶抑制剂.
    摘要:黄嘌呤氧化酶(xo)在产生尿酸中起着重要作用,因此xo抑制剂被认为是高尿酸血症和痛风的有前途的疗法之一.我们先前已经报道了一系列带有吡唑骨架的xo抑制剂,以扩展当前xo抑制剂的化学空间.在这里,我们描述了进一步的结构优化,以通过用该领域未开发的5个杂环骨架取代非布索坦的噻唑环来探索最佳杂环.所有这些努力导致了化合物8的鉴定,该化合物是一种具有新型2-苯基噻唑-4-羧酸支架的有效xo抑制剂(ic50 = 48.6 Nm).此外,铅化合物8在草酸钾-次黄嘌呤诱导的高尿酸血症小鼠中表现出低尿酸作用.
    DOI:10.1016/j.Bmcl.2019.01.005

    海关参考信息

    专利信息


    专利号:US-2013012719-A1
    优先权日:2011-07-08
    标 题 :Convenient Synthesis of Azolines to Azoles
    发明人:WILLIAMS TRAVIS J; DAWSEY ANNA C; LI VINCENT; HAMILTON KIMBERLY C; WANG JIANMEI
    权利人:UNIV SOUTHERN CALIFORNIA; WILLIAMS TRAVIS J; DAWSEY ANNA C; LI VINCENT; HAMILTON KIMBERLY C; WANG JIANMEI
    摘要:Azolines are oxidized in the presence of a copper-containing catalyst to azoles in the presence of molecular oxygen. A synthetic scheme converting azolines azoles is also provided.

    专利号:WO-2006079916-A1
    优先权日:2005-01-26
    标 题 :Thieno [2,3-d] pyrimidine compounds as inhibitors of adp-mediated platelets aggregation
    发明人:ENNIS MICHAEL DALTON; KORTUM STEVEN WADE; RAHMAN HAYAT; SCHWEITZER BARBARA ANN; TENBRINK RUTH ELIZABETH
    权利人:PHARMACIA & UPJOHN CO LLC; ENNIS MICHAEL DALTON; KORTUM STEVEN WADE; RAHMAN HAYAT; SCHWEITZER BARBARA ANN; TENBRINK RUTH ELIZABETH
    摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I): wherein A1, A2, A3, A4, A5, A6, A7, A8, X4, X6, R2, R4, R5, and R6 are as defined in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

    专利号:US-2006211603-A1
    优先权日:2004-08-18
    标 题:Ramoplanin derivatives possessing antibacterial activity
    发明人:RAJU BORE G; CIABATTI ROMEO; MAFFIOLI SONIA I; SINGH UPINDER; ROMANO GABRIELLA; MICHELUCCI ELENA; TISENI PAOLO S; CANDIANI GIANPAOLO; KIM BUM; O'DOWD HARDWIN
    权利人:VICURON PHARM INC
    摘要:Novel ramoplanin derivatives are disclosed. These ramoplanin derivatives exhibit antibacterial activity. As the compounds of the subject invention exhibit potent activities against gram positive bacteria, they are useful antimicrobial agents. Methods of synthesis and of use of the compounds are also disclosed.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Kikelj, D.; Urleb, U., Science of Synthesis, (2002) 11, 770.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知